Radiation response enhanced by inhibition of XPO1 in preclinical rectal cancer models

被引：4
|
作者：
von Fallois, Moritz [1 ]
Depping, Reinhard [1 ]
机构：
[1] Univ Lubeck, Inst Physiol, Ratzeburger Allee 160, D-23562 Lubeck, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2016年 / 192卷 / 12期
关键词：
D O I：
10.1007/s00066-016-1060-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：961 / 962
页数：2
相关论文
共 50 条
  • [21] Xpo1 Inhibition: A Promising Therapeutic Strategy in Thymic Epithelial Tumors
    Conforti, Fabio
    De Pas, Tommaso
    Alberobello, AnnaT.
    Rao, Guanhua
    Wang, Yisong
    Giaccone, Giuseppe
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S254 - S254
  • [22] Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias
    Walker, Christopher J.
    Oaks, Joshua J.
    Santhanam, Ramasamy
    Neviani, Paolo
    Harb, Jason G.
    Ferenchak, Gregory
    Ellis, Justin J.
    Landesman, Yosef
    Eisfeld, Ann-Kathrin
    Gabrail, Nash Y.
    Smith, Carrie L.
    Caligiuri, Michael A.
    Hokland, Peter
    Roy, Denis Claude
    Reid, Alistair
    Milojkovic, Dragana
    Goldman, John M.
    Apperley, Jane
    Garzon, Ramiro
    Marcucci, Guido
    Shacham, Sharon
    Kauffman, Michael G.
    Perrotti, Danilo
    BLOOD, 2013, 122 (17) : 3034 - 3044
  • [23] Deconstructing protein and gene expression pathways to define the anticancer effects of XPO1 inhibition in ovarian cancer
    Evans, Brad R.
    Silvers, Thomas R.
    Chen, Ying A.
    Garcia, Jason
    Camacho, Catalina
    Sharp, Andrew J.
    Garag, Paras
    Koduru, Srinivas V.
    Billaud, Jean-Noel
    Halpert, Richard L.
    Dottino, Peter R.
    Landesman, Yosef
    Shacham, Sharon
    Martignetti, John A.
    CANCER RESEARCH, 2015, 75
  • [24] Discovery, Validation and Mechanistic Study of XPO1 Inhibition in the Treatment of Triple-Negative Breast Cancer
    Paulson, Amy L.
    Gruener, Robert F.
    Lee, Adam M.
    Huang, R. Stephanie
    CANCERS, 2024, 16 (23)
  • [25] Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer
    Chen, Ying
    Camacho, Sandra Catalina
    Silvers, Thomas R.
    Razak, Albiruni R. A.
    Gabrail, Nashat Y.
    Gerecitano, John F.
    Kalir, Eva
    Pereira, Elena
    Evans, Brad R.
    Ramus, Susan J.
    Huang, Fei
    Priedigkeit, Nolan
    Rodriguez, Estefania
    Donovan, Michael
    Khan, Faisal
    Kalir, Tamara
    Sebra, Robert
    Uzilov, Andrew
    Chen, Rong
    Sinha, Rileen
    Halpert, Richard
    Billaud, Jean-Noel
    Shacham, Sharon
    McCauley, Dilara
    Landesman, Yosef
    Rashal, Tami
    Kauffman, Michael
    Mirza, Mansoor R.
    Mau-Sorensen, Morten
    Dottino, Peter
    Martignetti, John A.
    CLINICAL CANCER RESEARCH, 2017, 23 (06) : 1552 - 1563
  • [26] Exportin 1 (XPO1) inhibition alone or in combination as a novel therapeutic strategy in osteosarcoma
    Graves, Laurie
    Rupprecht, Gabrielle
    Altunel, Erdem
    Flamant, Etienne M.
    Rao, Sneha
    Sivara, Dharshan
    Lazarides, Alexander L.
    Hoskinson, Sarah M.
    Sheth, Maya U.
    Cheng, Serene
    Kim, So Young
    Ware, Kathryn E.
    Agarwal, Anika
    Cullen, Mark M.
    Syal, Casey
    Selmic, Laura E.
    Everitt, Jeffrey I.
    McCall, Shannon J.
    Eward, Cindy
    Kashyap, Trinayan
    Maloof, Marie
    Walker, Christopher J.
    Landesman, Yosef
    Wagner, Lars
    Eward, William C.
    Hsu, David S.
    Somarelli, Jason A.
    CANCER RESEARCH, 2022, 82 (12)
  • [27] Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication
    Rahman, Masmudur M.
    Estifanos, Bereket
    Glenn, Honor L.
    Gutierrez-Jensen, Ami D.
    Kibler, Karen
    Li, Yize
    Jacobs, Bertram
    Mcfadden, Grant
    Hogue, Brenda G.
    VIRUSES-BASEL, 2025, 17 (02):
  • [28] Viewpoint Exportin(g) precision oncology beyond genomics with XPO1 inhibition
    Gouda, Mohamed A.
    Subbiah, Vivek
    MED, 2022, 3 (11): : 730 - 732
  • [29] XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB
    Galinski, Basia
    Luxemburg, Marcus
    Landesman, Yosef
    Pawel, Bruce
    Johnson, Katherine J.
    Master, Stephen R.
    Freeman, Kevin W.
    Loeb, David M.
    Hebert, Jean M.
    Weiser, Daniel A.
    TRANSLATIONAL ONCOLOGY, 2021, 14 (08):
  • [30] XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
    Gravina, Giovanni Luca
    Tortoreto, Monica
    Mancini, Andrea
    Addis, Alessandro
    Di Cesare, Ernesto
    Lenzi, Andrea
    Landesman, Yosef
    McCauley, Dilara
    Kauffman, Michael
    Shacham, Sharon
    Zaffaroni, Nadia
    Festuccia, Claudio
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
12345